# dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate

NDC: 70010-033
Generic name: dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate
Labeler / Manufacturer: Granules Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20230220

FDA application: ANDA217027

## Active ingredients

- AMPHETAMINE ASPARTATE MONOHYDRATE: 6.25 mg/1
- AMPHETAMINE SULFATE: 6.25 mg/1
- DEXTROAMPHETAMINE SACCHARATE: 6.25 mg/1
- DEXTROAMPHETAMINE SULFATE: 6.25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70010-033"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70010-033
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8c672e06-0778-4a7d-b398-5bcbf2a73f12